1. Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. (May 2018) Authors: Tutt, Andrew; Tovey, Holly; Cheang, Maggie; Kernaghan, Sarah; Kilburn, Lucy; Gazinska, Patrycja; Owen, Julie; Abraham, Jacinta; Barrett, Sophie; Barrett-Lee, Peter; Brown, Robert; Chan, Stephen; Dowsett, Mitchell; Flanagan, James; Fox, Lisa; Grigoriadis, Anita; Gutin, Alexander; Harper-Wynne, Cat... Journal: Nature medicine Issue: Volume 24:Number 5(2018) Page Start: 628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial. Issue 7 (July 2019) Authors: Judson, Ian; Morden, James P; Kilburn, Lucy; Leahy, Michael; Benson, Charlotte; Bhadri, Vivek; Campbell-Hewson, Quentin; Cubedo, Ricardo; Dangoor, Adam; Fox, Lisa; Hennig, Ivo; Jarman, Katy; Joubert, Warren; Kernaghan, Sarah; López Pousa, Antonio; McNeil, Catriona; Seddon, Beatrice; Snowdon, Clai... Journal: Lancet oncology Issue: Volume 20:Issue 7(2019) Page Start: 1023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of a pre-constructed relative induction score (RIS) curve for prediction of CYP3A4 induction response in vivo. Issue 1 (January 2019) Authors: Zhang, George; Ho, Thuy; Clark, Robert. J.; Trisdale, Sarah; Choughule, Kanika; Fox, Lisa; Ramsden, Diane Journal: Drug metabolism and pharmacokinetics Issue: Volume 34:Issue 1(2019)Supplement Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗